"Fatty Acids, Omega-3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of unsaturated fatty acids occurring mainly in fish oils, with three double bonds at particular positions in the hydrocarbon chain.
Descriptor ID |
D015525
|
MeSH Number(s) |
D10.212.302.380.410 D10.251.355.337 D10.627.430.450
|
Concept/Terms |
Fatty Acids, Omega-3- Fatty Acids, Omega-3
- n-3 Fatty Acids
- n 3 Fatty Acids
- n-3 Polyunsaturated Fatty Acid
- n 3 Polyunsaturated Fatty Acid
- n-3 PUFA
- PUFA, n-3
- n 3 PUFA
- Omega 3 Fatty Acids
- n3 PUFA
- PUFA, n3
- n3 Polyunsaturated Fatty Acid
- n3 Oils
- n-3 Oils
- n 3 Oils
- Omega-3 Fatty Acids
- n3 Fatty Acid
- Fatty Acid, n3
|
Below are MeSH descriptors whose meaning is more general than "Fatty Acids, Omega-3".
Below are MeSH descriptors whose meaning is more specific than "Fatty Acids, Omega-3".
This graph shows the total number of publications written about "Fatty Acids, Omega-3" by people in this website by year, and whether "Fatty Acids, Omega-3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 2 | 0 | 2 |
2013 | 3 | 0 | 3 |
2014 | 1 | 1 | 2 |
2015 | 1 | 1 | 2 |
2016 | 1 | 2 | 3 |
2017 | 2 | 0 | 2 |
2018 | 3 | 2 | 5 |
2019 | 1 | 0 | 1 |
2020 | 2 | 0 | 2 |
2021 | 2 | 0 | 2 |
2022 | 4 | 0 | 4 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fatty Acids, Omega-3" by people in Profiles.
-
Omega-3 long chain polyunsaturated fatty acids as a potential treatment for reducing dysmenorrhoea pain: Systematic literature review and meta-analysis. Nutr Diet. 2024 Feb; 81(1):94-106.
-
Effects of omega-3 supplementation on quality of life, nutritional status, inflammatory parameters, lipid profile, exercise tolerance and inhaled medications in chronic obstructive pulmonary disease. Ann Palliat Med. 2022 Sep; 11(9):2819-2829.
-
Maternal Pyrroloquinoline Quinone Supplementation Improves Offspring Liver Bioactive Lipid Profiles throughout the Lifespan and Protects against the Development of Adult NAFLD. Int J Mol Sci. 2022 May 27; 23(11).
-
Effects of Omega-3-6-9 fatty acid supplementation on behavior and sleep in preterm toddlers with autism symptomatology: Secondary analysis of a randomized clinical trial. Early Hum Dev. 2022 06; 169:105588.
-
Randomized Controlled Trial of Omega-3 and -6 Fatty Acid Supplementation to Reduce Inflammatory Markers in Children with Autism Spectrum Disorder. J Autism Dev Disord. 2022 Dec; 52(12):5342-5355.
-
Associations Between Erythrocyte Membrane Fatty Acid Compositions and Biomarkers of Vascular Health in Adults With Type 1 Diabetes With and Without Insulin Resistance: A Cross-Sectional Analysis. Can J Diabetes. 2022 Mar; 46(2):111-117.
-
Farmed Mussels: A Nutritive Protein Source, Rich in Omega-3 Fatty Acids, with a Low Environmental Footprint. Nutrients. 2021 Mar 29; 13(4).
-
Omega-3 polyunsaturated fatty acid supplementation versus placebo on vascular health, glycaemic control, and metabolic parameters in people with type 1 diabetes: a randomised controlled preliminary trial. Cardiovasc Diabetol. 2020 08 12; 19(1):127.
-
Human skeletal muscle metabolic responses to 6 days of high-fat overfeeding are associated with dietary n-3PUFA content and muscle oxidative capacity. Physiol Rep. 2020 08; 8(16):e14529.
-
Supplementing Mothers and their Offspring with Long-Chain ?-3 PUFAs Offers no Benefit Compared with Placebo in Infant Development. J Nutr. 2019 03 01; 149(3):357-358.